Anika Therapeutics Inc (ANIK)

EBITDA Growth

291.57%

Quarterly · Period ending:

ANIK logo

ANIK EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported291.57%
ANIK Quarterly EBITDA YoY % (-25.00% → 291.57%)
High-resolution chart · PNG

ANIK ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
291.5686%
-49.9341%
-92.152%
96.7234%
-402.4911%
5.4402%
1,237.8215%
-626.9946%
75.625%
71.5467%
172.7706%
-87.3058%
13.2075%
-13,533.3333%
40.3459%
-230.9257%
143.8469%
216.6667%
-78.0203%
622.3443%
41.1084%
-101.5531%
-140.5115%
-102.0125%
-112.0585%
-55.1586%
-43.6427%
34.4934%
7.2796%
223.7867%
4.1227%
-12.0739%
-32.2462%
-169.4457%
-21.1944%
-21.2427%
29.8447%
-22.5818%
-24.0767%
10.886%
16.0863%
81.5273%
36.5%
14.2557%
-24.0779%
-74.3978%
12.1989%
29.4802%
58.0758%
312.4591%
2.5174%
127.1329%
68.8331%
98.4298%
92.3103%
-18.8547%
66.7911%
450.2381%
78.7356%
131.8674%
103.8513%
-52.7353%
-17.4808%
3.0445%
16.9357%
55.1013%
153.2922%
51.4308%
73.1729%
0.4783%
-33.4298%
-35.666%
-42.511%
-45.409%
150.0482%
14.5112%
-19.1591%
22.8994%
-1.2528%
-55.2636%
-7.9287%
-41.1472%
-62.2283%
138.7707%
42.6027%
58.8382%
135.8974%
332.7366%
1,049.6063%
561.6858%
23.1603%
156.4504%
113.4073%
83.6454%
463.1932%
36.1122%
62.9291%
22.8717%
-110.3018%
24.17%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.